0.000USD0.000Pre-market 07/28, 09:30 (ET)
45.28BMarket Cap
36.91P/E TTM
Key Figures
9.890Open
10.040High
87.40KVolume
36.91P/E TTM
17.21P/E Dynamic
0.054Dividend TTM
0.00%Turnover Ratio
9.940Prev. Close
9.850Low
153.21KTurnover
31.40P/E Static
2.03P/B
0.53%Div Yield TTM
5.02%ROA
11.42052wk High
-0.04Volume Ratio
1.44BNet Profit
4.45BShares
0.2755EPS TTM
0.13Beta
10.23%ROE
8.71052wk Low
1.91%Amplitude
64.19%Gross Margin
45.28BMarket Cap
9.09Reward/Risk
0.83%Risk Rate
Currency: USD Updated: 2026-07-27 Key Insights
Haleon PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 65 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.63.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Haleon PLC Highlights
StrengthsRisks
Haleon PLC News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Haleon PLC Info
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Ticker SymbolHLN
CompanyHaleon PLC
CEOMcnamara (Brian)
Websitehttps://www.haleon.com/
Shareholders
FAQs
What is the current price of Haleon PLC (HLN)?
The current price of Haleon PLC (HLN) is 9.95.
What is the symbol of Haleon PLC?
The ticker symbol of Haleon PLC is HLN.
What is the 52-week high of Haleon PLC?
The 52-week high of Haleon PLC is 11.42.
What is the 52-week low of Haleon PLC?
The 52-week low of Haleon PLC is 8.71.
What is the market capitalization of Haleon PLC?
The market capitalization of Haleon PLC is 44.29B.
Is Haleon PLC (HLN) currently rated as Buy, Hold, or Sell?
According to analysts, Haleon PLC (HLN) has an overall rating of Buy, with a price target of 10.63.
What is the Earnings Per Share (EPS TTM) of Haleon PLC (HLN)?
The Earnings Per Share (EPS TTM) of Haleon PLC (HLN) is 0.50.
